18F-SynVesT-1正电子发射断层成像在体内识别II型局灶性皮质发育不良的突触囊泡蛋白2A皮质异常
研究纳入16例确诊II型局灶性皮质发育不良(FCD II)患者和16名健康对照,用新型示踪剂18F-SynVesT-1行PET显像评估突触囊泡糖蛋白2A(SV2A)异常,并与18F-FDG比较。FCD II病灶18F-SynVesT-1摄取较对侧和对照显著减低,14例(87.5%)显示低摄取,病灶定位准确率高于MRI(43.8%)(P < 0.05),且异常模式较18F-FDG更局限。
要点
- FCD II病灶18F-SynVesT-1摄取较对侧和对照显著减低。
- 18F-SynVesT-1 PET在14例(87.5%)显示病灶低摄取,定位准确率高于MRI(43.8%)(P < 0.05)。
- FCD II病灶18F-SynVesT-1异常模式较18F-FDG更局限(P < 0.05)。
核心结论
- 18F-SynVesT-1 SV2A PET对FCD II病灶定位准确率高于MRI,且异常模式较18F-FDG PET更局限。
研究设计与样本
- 研究纳入16例确诊FCD II患者和16名健康对照;FCD II患者均行MRI及18F-SynVesT-1与18F-FDG静态PET,对照仅行MRI及18F-SynVesT-1 PET。
主要发现
- FCD II患者脑内病灶18F-SynVesT-1摄取较对侧相应区域和对照脑显著减低。
- 18F-SynVesT-1 PET在14例(87.5%)FCD II患者显示病灶低摄取,与18F-FDG PET检出的低代谢相对应,病灶定位准确率高于MRI(43.8%)(P < 0.05)。
- 不对称指数分析显示,病灶内各示踪剂SUVr间无显著差异(P > 0.05),且18F-SynVesT-1 SUVr与18F-FDG SUVr跨受试者相关(R2 = 0.41,P = 0.008)。
- 视觉评分显示,FCD II病灶中18F-SynVesT-1摄取减低模式较18F-FDG摄取减低更局限(P < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The loss of synaptic vesicle glycoprotein 2A (SV2A) is well established as the major correlate of epileptogenesis in focal cortical dysplasia type II (FCD II), but this has not been directly tested in vivo. In this positron emission tomography (PET) study with the new tracer 18F-SynVesT-1, we evaluated SV2A abnormalities in patients with FCD II and compared the pattern to 18F-fluorodeoxyglucose (18F-FDG). METHODS: Sixteen patients with proven FCD II and 16 healthy controls were recruited. All FCD II patients underwent magnetic resonance imaging (MRI) and static PET imaging with both 18F-SynVesT-1 and 18F-FDG, while the controls underwent MRI and PET with only 18F-SynVesT-1. Visual assessment of PET images was undertaken. The standardized uptake values (SUVs) of 18F-SynVesT-1 were computed for regions of interest (ROIs), along with SUV ratio (SUVr) between ROI and centrum semiovale (white matter). Asymmetry indices (AIs) were analyzed between the lesion and the contralateral hemisphere for intersubject comparisons. RESULTS: Lesions in the brains of FCD II patients had significantly reduced 18F-SynVesT-1 uptake compared with contralateral regions, and brains of the controls. 18F-SynVesT-1 PET indicated low lesion uptake in 14 patients (87.5%), corresponding to hypometabolism detected by 18F-FDG PET, with higher accuracy for lesion localization than MRI (43.8%) (P < 0.05). AI analyses demonstrated that in the lesions, SUVr for each of the radiotracers were not significantly different (P > 0.05), and 18F-SynVesT-1 SUVr correlated with that of 18F-FDG across subjects (R2 = 0.41, P = 0.008). Subsequent visual ratings indicated that 18F-SynVesT-1 uptake had a more restricted pattern of reduction than 18F-FDG uptake in FCD II lesions (P < 0.05). CONCLUSION: SV2A PET with 18F-SynVesT-1 shows a higher accuracy for the localization of FCD II lesions than MRI and a more restricted pattern of abnormality than 18F-FDG PET.
引用
- Tang Y, Yu J, Zhou M, et al. Cortical abnormalities of synaptic vesicle protein 2A in focal cortical dysplasia type II identified in vivo with 18F-SynVesT-1 positron emission tomography imaging. Eur J Nucl Med Mol Imaging. 2022. PMID: 34978594. doi:10.1007/s00259-021-05665-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。